Source: Eur Respir J 2014; 43: 1217-1219



Rating:

Share or cite this content

Citations should be made in the following way:
Saleh Aarash D., Hurst John R.. How to assess the severity of bronchiectasis. Eur Respir J 2014; 43: 1217-1219

Member's Comments

No comment yet.

Related content which might interest you: Using characteristics of asthma phenotypes to determine exacerbation severity Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 HRCT score to control and evaluate the prognosis in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Predictive factors of bronchiectasis acute exacerbation severity Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 The bronchiectasis severity index and FACED score for bronchiectasis Source: Eur Respir J 2016; 47: 382-384 Year: 2016 Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002 HRCT quantitative parameters may help to define the contribute of emphysema and chronic bronchitis in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 10s Year: 2001 Bronchiectasis  contributes to the severity of COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001 Evaluating disease severity in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017 Year: 2017 Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 251s Year: 2002 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Improved spirometric index to discriminate the severity of centrilobular emphysema Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Assessment of disease severity using imaging scores in pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity Source: International Congress 2017 – Management of asthma in different situations Year: 2017 A study to evaluate the lung function in bronchiectasis Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Estimating the effectiveness of pulmonary rehabilitation for different severity of COPD, ILD and IPF Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 Clinical and functional profile of patients with non-cystic fibrosis bronchiectasis according to the presence of chronic bronchial infection Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019